Ayman Qasrawi

University of Kentucky — United States

Medicine · Health Sciences

10h-index244citations86works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(15), Acute Lymphoblastic Leukemia research(9), Multiple Myeloma Research and Treatments(8), Chronic Myeloid Leukemia Treatments(8), Metastasis and carcinoma case studies(6)

Publications86 total

Retrospective Comparison between Multiple Hyperbaric Oxygen, Single Hyperbaric Oxygen Treatments and No Hyperbaric Oxygen Treatments in Patients with Multiple Myeloma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplants
Transplantation and Cellular Therapy·2026Open Access
Ziftomenib in combination with venetoclax and azacitidine in newly diagnosed NPM1-m acute myeloid leukemia: Phase 1b results from KOMET-007
Blood·2025· 2 citedOpen Access
All-Cause and Exacerbation-Related Readmissions in Thrombotic Microangiopathy Requiring Plasmapheresis: A Population-Based Cohort Study
Turkish Journal of Hematology·2025Open Access
Genetic risk model to predict outcomes for AML treated with HMA and venetoclax
Blood·2025Open Access
Outcomes with liposomal daunorubicin/cytarabine – a single-center experience
Blood·2025Open Access
Prognostic impact of co-occurring mutations in NPM1-mutated Acute Myeloid Leukemia
Blood·2025Open Access
Impact of induction regimen and co-mutations on outcomes in AML with myelodysplasia-related changes
Blood·2025Open Access
Efficacy and safety of clia plus venetoclax as salvage therapy for relapsed or refractory Acute Myeloid Leukemia
Blood·2025
TBI based VS chemotherapy based myeloablative conditioning in T cell replete haploidentical transplant
Blood·2025
EP.13.29 Safety and Efficacy of DLL3 CAR-T Cells Armored With dnTGFBR2 in a Patient With Recurrent Small-Cell Lung Cancer
Journal of Thoracic Oncology·2025
The impact of the use of hypomethylating agents prior to reduced intensity conditioning allogeneic bone marrow transplant among patients with MDS.
Journal of Clinical Oncology·2025
AI-driven risk stratification for disease progression after allo-SCT in AML.
Journal of Clinical Oncology·2025
Assessing the role of cytarabine-based regimens in mantle cell lymphoma: A real world study.
Journal of Clinical Oncology·2025
Cryptic to conventional cytogenetics: Philadelphia-like ALL presenting with hypereosinophilia
BMJ Case Reports·2025· 1 citedOpen Access
Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (<scp>AML</scp>) in Obese Patients
European Journal Of Haematology·2024
Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: Final Analysis of the Multicenter Phase II Randomized Clinical Trial
Blood·2024· 1 citedOpen Access
Outcomes of Rituximab and Bendamustine Induction Regimen VS Cytarabine-Based Induction for Patients with Mantle Cell Lymphoma
Blood·2024
Gilteritinib Results in Higher Remission and Transplant Rates Than Midostaurin but Does Not Increase the Post-Induction Mutational MRD Negative Rate: Results of the Phase 2 Randomized Precog 0905 Study in Newly Diagnosed <i>FLT3</i> Mutated AML
Blood·2024· 6 citedOpen Access
Efficacy of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm, an Interrupted Time Series Analysis
Blood·2024
Appropriate Timing of Allogeneic Bone Marrow Transplant in Patients with Myelodysplastic Syndrome
Blood·2024
page 1 of 5Next →

Frequent Co-authors

Omar Abughanimeh(21), Mouhanna Abu Ghanimeh(19), Reinhold Munker(9), Reshma Ramlal(7), Yanal Alnimer(7), Gerhard Hildebrandt(6), Sakher Albadarin(5), Gregory Monohan(5), Osama Kaddourah(4), Waled Bahaj(4), Osama Yousef(4), Zena Chahine(4), Fevzi Yalniz(4), Laith Al Momani(3), Sheshadri Madhusudhana(3), Mohammad Tahboub(3), Chaitanya Iragavarapu(3), Eric Huselton(3), Brea Lipe(3), Melissa Kesler(2)